Reg. no. 5567045140 · Other research and experimental development on natural sciences and engineering · STOCKHOLM
InDex Pharmaceuticals AB is registered with the legal form Limited company, is based in STOCKHOLM and is active in Other research and experimental development on natural sciences and engineering. Revenue for 2024 was 10.8 MSEK.
Fiscal year ending 2024-12-31 · Amounts in SEK
Net revenue
10.8 MSEK
▼ −89%Operating result
-13.4 MSEK
▲ +87%Net result
-2.2 MSEK
▲ +97%Employees (annual report)
2
▼ −60%Total assets
19.1 MSEK
Equity
18.8 MSEK
Equity ratio
98.7 %
Profit margin
−20.2 %
MSEK
InDex Pharmaceuticals AB reported a 88.9 % decline in net sales in 2024, to 10.8 MSEK. The operating margin declined from -102.6 % to -123.7 % in 2024. InDex Pharmaceuticals AB held cash corresponding to roughly 55.2 % of total assets at the period end. In 2024, net sales corresponded to roughly 5.4 MSEK per employee (2 employees).
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
InDex Pharmaceuticals AB's reg. no. is 5567045140.
InDex Pharmaceuticals AB reported revenue of 10.8 MSEK for the fiscal year 2024.
No — InDex Pharmaceuticals AB reported a net result of -2.2 MSEK for 2024.
InDex Pharmaceuticals AB had 2 employees as of the most recently reported period (2024).
InDex Pharmaceuticals AB is registered under Other research and experimental development on natural sciences and engineering.
InDex Pharmaceuticals AB is based in STOCKHOLM.
arkivnord